Apocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators
| dc.contributor.author | Ahmed, Khaled Abdul-aziz | |
| dc.contributor.author | Alqaisi, Khalid M. | |
| dc.contributor.author | Ibrahim, Noralhuda Ayad | |
| dc.contributor.author | Al-Qaisi, Talal Salem | |
| dc.contributor.author | E.T.A.L.. | |
| dc.date.accessioned | 2026-01-12T05:46:50Z | |
| dc.date.available | 2026-01-12T05:46:50Z | |
| dc.date.issued | 2025 | |
| dc.description | Liver fibrosis (LF) is a chronic health disorder that occurs in progressive phases of all chronic liver diseases, characterized by tissue fibrosis, necrosis, and numerous regenerative hepatic nodules. | |
| dc.description.abstract | The liver has a tremendous regeneration potential, yet chronic liver injury poses a life-threatening condition if not managed appropriately. Apocynin, an NADPH oxidase inhibitor, has been a central focus of attention in recent years due to its significant antioxidant/anti-inflammatory potentials. In this study, we evaluated the acute toxicity and hepatoprotective effects of Apocynin against thioacetamide (TAA)-induced liver fibrosis in rats. Liver fibrosis was induced by 200 mg/kg TAA three times/week for two months, along with treatment with distilled water (positive control), silymarin (reference, 50 mg/kg), or apocynin (50 and 100 mg/kg/day). Hepatic tissues were screened for histopathological, biochemical, and immunohistochemical changes, while hepatic homogenate was examined for the antioxidant contents (catalase, CAT; superoxide dismutase, SOD) and MDA levels. Apocynin treatment showed significant hepatoprotective effects against TAA-hepatotoxicity, evidenced by reduced hepatic tissue alterations with a slight fibroplasia, reduction of hepatomegaly, less hepatic nodules/necrosis, and recovered hepatic function. Additionally, apocynin administration reduced oxidative stress by lowering pro-oxidants (MDA) and up-regulating antioxidants (SOD and CAT). Furthermore, the anti-apoptotic and anti-fibrotic effects of apocynin were confirmed by reduced pro-apoptotic P53 proteins and β-catenin (tissue proliferation/aggregation enhancer). Apocynin treatment ameliorated ECM generation (lowered collagen bundles/fibrous septa) and reduced inflammatory (less TNf-α and IL-6 cytokines) mediators, all of which restored liver functional parameters (ALT, AST, ALP, and albumin). Apocynin attenuated TAA-mediated liver fibrosis by its modulatory potentials on several cytoprotective mechanisms associated with the oxidative stress/inflammation, making it a viable therapeutic source for liver fibrosis. Keywords: Apocynin, Liver Fibrosis, Thioacetamide, Antioxidants, Histopathology | |
| dc.identifier.citation | Ahmed, K. A. A., Alqaisi, K. M., Ibrahim, N. A., Abdullah, S. S., Jabbar, A. A., Saleh, G. N., ... & Althagbi, H. I. (2025). Apocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators. BMC Pharmacology and Toxicology, 26(1), 207. | |
| dc.identifier.doi | https://doi.org/10.1186/s40360-025-01041-8 | |
| dc.identifier.uri | https://repository.adu.ac.ae/handle/1/7928 | |
| dc.language.iso | en | |
| dc.publisher | Springer Nature | |
| dc.title | Apocynin ameliorates liver fibrosis events in vivo through modulation of oxidative stress, inflammatory, and apoptotic mediators | |
| dc.type | Article |
